A notable advancement in diabetes care is emerging with the release of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://rsahcsv719407.muzwiki.com/280674/groundbreaking_approach_tirzepatide_dose_for_glucose_control